Log in to save to my catalogue

Machine learning-based plasma metabolomics for improved cirrhosis risk stratification

Machine learning-based plasma metabolomics for improved cirrhosis risk stratification

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f406dfc9d68745eca6fec9194572a775

Machine learning-based plasma metabolomics for improved cirrhosis risk stratification

About this item

Full title

Machine learning-based plasma metabolomics for improved cirrhosis risk stratification

Publisher

England: BioMed Central Ltd

Journal title

BMC gastroenterology, 2025-02, Vol.25 (1), p.61-15, Article 61

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Cirrhosis is a leading cause of mortality in patients with chronic liver disease (CLD). The rapid development of metabolomic technologies has enabled the capture of metabolic changes related to the progression of cirrhosis.
This study used proton nuclear magnetic resonance (1 H-NMR) serum metabolomics data from the UK Biobank (UKB) and employed...

Alternative Titles

Full title

Machine learning-based plasma metabolomics for improved cirrhosis risk stratification

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f406dfc9d68745eca6fec9194572a775

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f406dfc9d68745eca6fec9194572a775

Other Identifiers

ISSN

1471-230X

E-ISSN

1471-230X

DOI

10.1186/s12876-025-03655-y

How to access this item